aTYR PHARMA INC (ATYR): Form 8-K filed 2026-11-13
- Accepted by EDGAR
- 2026-11-13 16:01 ET
- Event date
- 2026-11-13
- Accession no.
- 0001339970-26-000088
- Original filing
- SEC EDGAR filing index
AI summary of the filing text. It can contain mistakes; the original filing is authoritative.
aTyr Pharma regains compliance with Nasdaq minimum bid price requirement
aTyr Pharma received a Nasdaq letter on November 13, 2026 confirming it had regained compliance with the minimum bid price requirement. Its closing bid price was at $1.00 per share or greater for the last 10 consecutive business days. The company has no outstanding deficiency notices from Nasdaq as of the report date.
- Nasdaq notified aTyr on November 13, 2026 that it had regained compliance with Nasdaq Listing Rule 5550(a)(2).
- The closing bid price was at $1.00 per share or greater from October 30, 2026 to November 12, 2026.
- The company has no outstanding deficiency notices from Nasdaq as of the report date.
listing notice
Items reported
- Item 8.01: Other Events
A voluntary disclosure of an event the company considers important to security holders that no other Item covers, such as a dividend declaration, a buyback program, litigation updates or product news.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | 8-K | atyr-20261113.htm |
The summary above was generated by AI from the filing text and checked automatically against it. Read the original documents on SEC EDGAR. How to read an 8-K.